{
    "name": "StrategyBiotechNews",
    "symbol_sources": [
        {
            "asset_class": "us_equity",
            "sub_class": "biotech"
        }
    ],
    "data_providers": [
        {
            "asset_class": "us_equity",
            "data_type": "daily_ohlc",
            "provider": "polygon"
        },
        {
            "asset_class": "us_equity",
            "data_type": "news",
            "provider": "biopharmcatalyst"
        }
    ],
    "trade_config": {
        "starting_cash": 50000,
        "us_equity": {
            "type": "simple_fixed",
            /* allocate 1/4 of initial cash with each trade */
            "trade_size_in_dollars": 12500,
            "holding_period": "14_days"
        }
    },
    "specific_config": {
        "min_prev_daily_volume": 50e6,
        "max_prev_daily_volume": 500e9,
        "returns_window_beta_adj_z_leq_bound": -1.5,
        "returns_window_beta_adj_z_geq_bound": 1.5,
        "blacklisted_symbols": [],
        "text_filters": [
            "clincal",
            "trial",
            "study",
            "phase",
            "findings",
            "fda",
            "approve",
            "accepts",
            "U.S. Food and Drug Administration"
        ],
        "include_short_trades": true,
        "do_hedge": true,
        /* Note, the next option will change the the trade size to no longer be simple fixed */
        /* instead, the trade size will be scaled by the ratio of the index ETF to the traded asset volatility */
        "scale_trade_to_etf_vol": false,
        "exclude_intraday": true
    }
}